Question 1

How many shares of VYNE does CITADEL ADVISORS LLC own?

Accepted Answer

As of 2026-Q1, CITADEL ADVISORS LLC holds 514,443 shares of VYNE (VYNE THERAPEUTICS INC).

Question 2

What is CITADEL ADVISORS LLC's VYNE position worth?

Accepted Answer

As of 2026-Q1, CITADEL ADVISORS LLC's VYNE position is worth $307,380.

Question 3

Is CITADEL ADVISORS LLC buying or selling VYNE?

Accepted Answer

In 2026-Q1, CITADEL ADVISORS LLC increased their VYNE position (+1585.3% change in shares).

Question 4

When did CITADEL ADVISORS LLC first buy VYNE?

Accepted Answer

Based on available 13F filings, CITADEL ADVISORS LLC first reported a position in VYNE in 2024-Q2. They have held the position across 18 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Increased	514,443	+1585.3%	$307,380	0.0%	$0.60	26
2025-Q4	New	30,526	—	$17,708	0.0%	$0.58	28
2025-Q3	Exited	0	-100.0%	$0	0.0%	$0.34	0
2025-Q2	Decreased	1M	-5.5%	$1.7M	0.0%	$1.65	0
2025-Q1	Decreased	1.1M	-10.6%	$1.7M	0.0%	$1.58	0
2024-Q4	Increased	1.2M	+3.6%	$4.1M	0.0%	$3.35	28
2024-Q3	Decreased	1.2M	-1.9%	$2.2M	0.0%	$1.88	0
2024-Q2	Increased	1.2M	+2.5%	$2.4M	0.0%	$1.97	27